Tirzepatide is designed to support weight management and enhance overall metabolic health. As a dual-action therapy, it targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, delivering a comprehensive approach to appetite control, weight loss, and blood sugar regulation.
Prescription Appetite Suppression
Tirzepatide helps curb appetite and reduce food cravings, making it easier to achieve and maintain weight loss.
Clinically Proven Weight Loss Aid Backed by extensive clinical research
Tirzepatide has been shown to support significant weight reduction, with some patients in studies losing up to 22.5% of their body weight.
Metabolic Health Booster
By lowering blood sugar, improving insulin sensitivity, and reducing key risk factors, Tirzepatide promotes better metabolic health and helps protect against conditions such as type 2 diabetes, high blood pressure, and cardiovascular disease.
Enhanced Quality of Life
Achieving a healthier weight with Tirzepatide may ease fatigue, reduce joint pain, improve mobility, and boost energyāhelping patients feel better and live more actively.
This product is prescribed by a licensed healthcare provider based on the individual needs. These statements and the product have not been evaluated or approved by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved, and their safety and efficacy have not been independently verified by the FDA. This information is provided for educational purposes only and should not be considered medical advice.
1. Tirzepatide Once Weekly for the Treatment of Obesity
2. Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
3. Efficacy and safety oftirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
4. Tirzepatide for Type 2 Diabetes Mellitus
5. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
6. NDA 215866-0001 , Mounjaro (tirzepatide), GIP/GLP-1 receptor agonistindication: An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
7. Tirzepatide Versus Insulin Glargine in Type 2 Diabetes and Increased Cardiovascular Risk – SURPASS-4
8. The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Tirzepatide is a treatment designed to support weight management and blood sugar control in adults. As a dual receptor agonist, it mimics the actions of two natural hormonesāGLP-1 and GIPāthat regulate appetite, insulin production, and digestion. By reducing hunger, slowing digestion, and improving blood sugar regulation, Tirzepatide helps promote sustainable weight loss and metabolic balance.
Tirzepatide supports weight loss by reducing hunger and enhancing feelings of fullness. It mimics two natural hormones in the bodyāGLP-1 and GIPāthat play key roles in regulating appetite and blood sugar levels. By slowing the emptying of the stomach, Tirzepatide helps you feel satisfied more quickly and stay full for longer, making it easier to manage calorie intake and support sustainable weight management.
Pharmacies may compound Tirzepatide with Vitamin B12 (cyanocobalamin), a key nutrient that supports energy metabolism and overall health. The addition of Vitamin B12 is intended to enhance the therapeutic benefits of treatment, making these formulations distinct from commercially available options. Each compound is prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act, ensuring compliance while addressing specific patient needs and providing personalized care solutions.
FrontCare partners with licensed pharmacies that operates in full compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act. This framework permits the compounding of medications such as Semaglutide and Tirzepatide when commercially available options do not meet a patientās specific needs. These compounded formulations can address individualized requirements, including customized dosing, alternative delivery methods, or sensitivities to standard ingredients.
Tirzepatide is generally considered safe when prescribed and monitored by a licensed healthcare provider. Like all medications, it may cause side effects. The most commonly reported are nausea, vomiting, diarrhea, and constipation, which are typically mild and tend to improve as the body adjusts to treatment.
In rare cases, more serious side effects can occur, including severe gastrointestinal issues or kidney problems. Because of this, it is essential to review the potential risks and benefits of Tirzepatide with your healthcare provider before starting therapy and to promptly report any side effects or concerns during treatment.
Both medications belong to a class known as GLP-1 receptor agonists (GLP-1 RAs), which mimic the effects of the natural hormone GLP-1 to help regulate blood sugar and appetite. Tirzepatide has an additional mechanism of action: it also mimics glucose-dependent insulinotropic polypeptide (GIP). This dual-action approachātargeting both GLP-1 and GIP receptorsāhas been shown in research to be more effective for weight loss compared to Semaglutide alone.
The package will include a vial of the medication, instructional materials and insulin needles.
To qualify for treatment, you must be at least 18 years old and either reside in, or be physically present in, a state where FrontCare services are available. Medical necessity must be established, and if required, our team can help coordinate recent lab results at your providerās request.
Certain medical conditions prevent eligibility, including type 1 diabetes, a history of chronic or medication-induced pancreatitis, severe gastrointestinal disease, current gallbladder problems (other than prior removal), retinal impairment or diabetic retinopathy, recent bariatric surgery, multiple endocrine neoplasia syndrome type 2 (MEN-2), or a history of medullary thyroid cancer. In addition, treatment is not appropriate during pregnancy or while nursing.
Ultimately, a licensed healthcare provider will make the final determination regarding eligibility for the weight loss program and may request additional medical information to ensure safe and appropriate care.
Tirzepatide may be especially beneficial for individuals with type 2 diabetes, as its dual action on GIP and GLP-1 receptors can enhance insulin secretion, improve glycemic control, and help lower blood sugar levels. It is also well-suited for those focused on weight management, since clinical studies have shown it can promote significant weight loss by reducing appetite and caloric intakeāmaking it a valuable option for people struggling with obesity or weight-related challenges.
For individuals with metabolic syndrome, Tirzepatide supports overall metabolic health by addressing hyperglycemia, insulin resistance, and excess weight at the same time. Patients with cardiovascular risk factors may also benefit, as improved blood sugar regulation and weight loss can help reduce risks associated with type 2 diabetes and heart disease. More broadly, those seeking comprehensive metabolic support may find this therapy advantageous, as it provides a multifaceted approach to managing blood sugar, weight, and long-term well-being.
Always follow the instructions provided by your healthcare provider or the detailed guidelines included with your medication to ensure safe and proper administration.
While a licensed medical professional will review your profile before prescribing Tirzepatide, it is important to also consult your primary care provider, who knows your complete medical history. This helps ensure safe, comprehensive, and personalized care, as your doctor may provide health insights not available through our service.
The protocol may vary depending on the prescribed tier. Always follow the exact dosage instructions provided by your healthcare provider, which will be included with your medication.
Your provider will guide you through the appropriate dosing schedule and adjustments. For a general overview of available dosing tiers, please refer to the product pages on our website.
Do not use if you have any of the following:
Talk to Your Healthcare Provider Be sure to inform your provider if you currently have or have ever had:
Your medication may arrive with or without a cold pack, depending on the pharmacy. Rest assured that the medication is safe for consumption regardless. To maintain its quality, we advise placing the vial in the refrigerator as soon as you receive it.
FrontCare partners with Pharmacies that may compound Semaglutide and Tirzepatode formulations with Vitamin B12 (cyanocobalamin). This essential nutrient plays a critical role in energy metabolism and overall health, enhancing the therapeutic benefits of treatment and making these compounded options distinct from standard commercially available alternatives.
Vitamin B12 belongs to a group of molecules called cobalamins, which include hydroxocobalamin, adenosylcobalamin, and cyanocobalamin. Each contains cobalt at its core; when cobalt interacts with water, its salts form a pink-colored solution, known as a metal aquo complex.
All compounded medications are prepared in compliance with Section 503A of the Federal Food, Drug, and Cosmetic Act, ensuring patient-specific formulations that meet high standards of safety and care.
The Platform gives you full access to the frontcare partner ecosystem: